Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.